Display options
Share it on

Alzheimers Dement. 2007 Apr;3(2):109-21. doi: 10.1016/j.jalz.2007.02.002.

The Memory and Aging Telephone Screen: development and preliminary validation.

Alzheimer's & dementia : the journal of the Alzheimer's Association

Laura A Rabin, Andrew J Saykin, Heather A Wishart, Katherine E Nutter-Upham, Laura A Flashman, Nadia Pare, Robert B Santulli

Affiliations

  1. Neuropsychology Program, Department of Psychiatry, Dartmouth Medical School/DHMC, Lebanon, NH, USA.

PMID: 19595923 PMCID: PMC2712946 DOI: 10.1016/j.jalz.2007.02.002

Abstract

BACKGROUND: Telephone interviews are widely used in geriatric settings to identify eligible research participants and to perform brief follow-up assessments of cognition. This article reports on the development and validation of the Memory and Aging Telephone Screen (MATS), a structured interview for older adults with mild cognitive impairment and/or significant memory complaints. We also developed three alternate forms of the MATS objective memory test to reduce practice effects engendered by multiple administrations.

METHODS: Participants were enrolled in a longitudinal study that included 120 older adults with amnestic mild cognitive impairment, subjective cognitive complaints but without deficit on neuropsychological tests, and demographically matched healthy controls. An additional 15 patients with mild probable Alzheimer's disease completed the alternative forms study. All participants received the original MATS version, and a subset (n = 90) later received two of three alternate forms.

RESULTS: The MATS was sensitive to group differences, and the alternate forms were equivalent. MATS objective memory test scores showed adequate stability during a period of 1 year and were moderately correlated with scores on a widely used list-learning test (California Verbal Learning Test, Second Edition).

CONCLUSIONS: The MATS, a repeatable telephone screen that includes objective and subjective memory assessments, is useful for detecting individuals in the preclinical and early stages of dementia. Results encourage use of the MATS as a reliable and valid cognitive screening tool in research and clinical settings. Longitudinal assessments are being performed to investigate the predictive validity of the MATS for cognitive progression in mild cognitive impairment.

References

  1. J Psychiatr Res. 1975 Nov;12(3):189-98 - PubMed
  2. Arch Clin Neuropsychol. 1995 Jan;10(1):21-6 - PubMed
  3. J Neurol Neurosurg Psychiatry. 2006 Apr;77(4):429-38 - PubMed
  4. Acta Neurol Scand Suppl. 2003;179:34-41 - PubMed
  5. Neurology. 2006 Sep 12;67(5):834-42 - PubMed
  6. J Geriatr Psychiatry Neurol. 1997 Oct;10(4):161-7 - PubMed
  7. Neurobiol Aging. 2006 Dec;27(12):1751-6 - PubMed
  8. Int J Geriatr Psychiatry. 2001 Feb;16(2):166-7 - PubMed
  9. Int J Geriatr Psychiatry. 2004 Sep;19(9):875-80 - PubMed
  10. J Intern Med. 2004 Sep;256(3):240-6 - PubMed
  11. J Intern Med. 2004 Sep;256(3):224-34 - PubMed
  12. Arch Clin Neuropsychol. 2005 Jun;20(4):517-29 - PubMed
  13. J Gerontol. 1982 May;37(3):323-9 - PubMed
  14. Acta Neurol Scand Suppl. 2003;179:52-76 - PubMed
  15. Psychol Med. 2002 Apr;32(3):483-91 - PubMed
  16. Br J Clin Psychol. 2003 Nov;42(Pt 4):407-25 - PubMed
  17. Int J Geriatr Psychiatry. 2003 Apr;18(4):318-24 - PubMed
  18. Neuropsychiatry Neuropsychol Behav Neurol. 1999 Oct;12(4):270-6 - PubMed
  19. J Intern Med. 2004 Sep;256(3):183-94 - PubMed
  20. Arch Neurol. 2003 Dec;60(12):1777-81 - PubMed
  21. Br J Gen Pract. 2002 Dec;52(485):1002-3 - PubMed
  22. Lancet Neurol. 2003 Jan;2(1):15-21 - PubMed
  23. Br J Clin Psychol. 1993 Sep;32(3):303-7 - PubMed
  24. J Geriatr Psychiatry Neurol. 1994 Jan-Mar;7(1):33-8 - PubMed
  25. Dementia. 1993 Mar-Apr;4(2):117-9 - PubMed
  26. J Geriatr Psychiatry Neurol. 1998 Spring;11(1):18-24 - PubMed
  27. J Neurol Neurosurg Psychiatry. 2006 Jun;77(6):714-8 - PubMed
  28. Arch Intern Med. 2001 Nov 12;161(20):2481-7 - PubMed
  29. Psychol Med. 1994 Feb;24(1):145-53 - PubMed
  30. Alzheimers Dement. 2005 Jul;1(1):55-66 - PubMed
  31. J Clin Exp Neuropsychol. 1991 Nov;13(6):933-49 - PubMed
  32. Arch Fam Med. 2000 Jun;9(6):527-32 - PubMed
  33. Biol Psychiatry. 1979 Oct;14(5):791-801 - PubMed
  34. J Geriatr Psychiatry Neurol. 1995 Oct;8(4):238-42 - PubMed
  35. J Psychiatr Res. 1982-1983;17(1):37-49 - PubMed
  36. J Am Geriatr Soc. 1992 Jul;40(7):697-702 - PubMed
  37. Psychol Med. 2003 Aug;33(6):1039-50 - PubMed
  38. J Am Geriatr Soc. 2003 Oct;51(10):1382-90 - PubMed
  39. Neurology. 2001 May 8;56(9):1133-42 - PubMed
  40. J Clin Exp Neuropsychol. 2002 Apr;24(2):168-75 - PubMed
  41. Neurology. 1984 Jul;34(7):939-44 - PubMed
  42. J Am Geriatr Soc. 1992 Sep;40(9):922-35 - PubMed
  43. Neuroepidemiology. 2005;25(1):19-25 - PubMed
  44. Neuropsychiatry Neuropsychol Behav Neurol. 2000 Oct;13(4):286-96 - PubMed
  45. Neurology. 2003 Jan 28;60(2):261-6 - PubMed
  46. Arch Neurol. 2001 Dec;58(12):1985-92 - PubMed
  47. Int J Geriatr Psychiatry. 2003 May;18(5):381-6 - PubMed
  48. Br J Psychiatry. 1968 Jul;114(512):797-811 - PubMed
  49. J Clin Psychiatry. 1987 Aug;48(8):314-8 - PubMed
  50. Alzheimers Dement. 2006 Apr;2(2):104-9 - PubMed
  51. Arch Clin Neuropsychol. 1998 Oct;13(7):623-8 - PubMed
  52. Am J Geriatr Psychiatry. 1998 Spring;6(2):176-9 - PubMed
  53. Int Psychogeriatr. 2002 Sep;14(3):273-89 - PubMed
  54. J Geriatr Psychiatry Neurol. 2004 Jun;17(2):81-7 - PubMed

Publication Types

Grant support